Search results
Results from the WOW.Com Content Network
Cariprazine, sold under the brand name Vraylar among others, is an atypical antipsychotic developed by Gedeon Richter, [8] which is used in the treatment of schizophrenia, bipolar mania, [9] bipolar depression, [10] and as an add-on therapy for major depressive disorder. [6]
COVID-19: Shionogi: 3C-like protease inhibitor Entecavir: HIV NRTI 2005 Etravirine (Intelence) [8] HIV NNRTI 2008 Famciclovir: Herpes Zoster: Guanosine analogue 1994 Fomivirsen: AIDS Anti-sense oligonucleotide: Anti-sense FDA-licensed in 1998; Withdrawn in EU (2002), US (2006) Fosamprenavir: HIV ViiV Healthcare: Amprenavir pro-drug: 2003 (FDA ...
Vraylar, an antipsychotic drug. Janumet; Janumet XR, diabetes drugs. ... Ozempic and similar drugs are in high demand, and as Medicare begins to cover the drugs for other FDA-approved uses, such ...
Bristol Myers wins US FDA approval for new type of schizophrenia drug. Bhanvi Satija and Michael Erman. September 27, 2024 at 3:06 AM ... AbbVie's Vraylar and generic drugs such as olanzapine ...
It is also approved for weight loss in those that are either obese or overweight with some weight-related illnesses Cymbalta ( duloxetine ) – an antidepressant of the serotonin-norepinephrine reuptake inhibitors class
The FDA issued a "study may proceed" letter 24 hours after their investigational new drug application. ... U.S.-Israeli NeuroRx and Relief Therapeutics <RLFB.S> for the use of Aviptadil to treat ...
National regulatory authorities have granted full or emergency use authorizations for 40 COVID-19 vaccines.. Ten vaccines have been approved for emergency or full use by at least one stringent regulatory authority recognized by the World Health Organization (WHO): Pfizer–BioNTech, Oxford–AstraZeneca, Sinopharm BIBP, Moderna, Janssen, CoronaVac, Covaxin, Novavax, Convidecia, and Sanofi ...
The Food and Drug Administration will authorize the emergency use of the antiviral remdesivir on COVID-19 patients as soon as Wednesday, a senior administration official told The New York Times.